HIV/AIDS and Tuberculosis in Central Asia

The countries of Central Asia are still at the earliest stages of an HIV/AIDS epidemic. However, there is cause for serious concern due to: the steep growth of new HIV cases in the region; the established related epidemics of injecting drug use, se...

Full description

Bibliographic Details
Main Authors: Godinho, Joana, Novotny, Thomas, Tadesse, Hiwote, Vinokur, Anatoly
Format: Publication
Language:English
en_US
Published: Washington, DC: World Bank 2013
Subjects:
ALS
HIV
TB
Online Access:http://documents.worldbank.org/curated/en/2003/11/2875686/hivaids-tuberculosis-central-asia
http://hdl.handle.net/10986/15061
id okr-10986-15061
recordtype oai_dc
repository_type Digital Repository
institution_category Foreign Institution
institution Digital Repositories
building World Bank Open Knowledge Repository
collection World Bank
language English
en_US
topic HIV AIDS INFECTIONS
TUBERCULOSIS EPIDEMICS
DRUG UTILIZATION
SEXUALLY TRANSMITTED INFECTIONS
UNEMPLOYMENT
IMPRISONMENT
POVERTY
HUMAN CAPITAL
ECONOMIC DEVELOPMENT
HEALTH SYSTEM MANAGEMENT
ECONOMIC ANALYSIS
STAKEHOLDER PARTICIPATION
EPIDEMIOLOGICAL INFORMATION
REGULATORY FRAMEWORK
PREVENTIVE HEALTH SERVICES
DIAGNOSTIC MEDICINE
TREATMENT
NONGOVERNMENTAL ORGANIZATIONS
STAKEHOLDER PARTICIPATION
ACQUIRED IMMUNE DEFICIENCY SYNDROME
ALS
CASE MANAGEMENT
CHILD TRANSMISSION
COMMERCIAL SEX
COMMERCIAL SEX WORKER
COMMERCIAL SEX WORKERS
CONDOMS
CRIME
DRUG ABUSE
DRUG RESISTANCE
DRUG TRAFFICKING
DRUG USERS
DRUGS
EFFECTIVE PREVENTION
EPIDEMIOLOGY
HARM REDUCTION
HEALTH CARE
HEALTH CARE SYSTEMS
HEALTH FOR ALL
HEALTH PROFESSIONALS
HEALTH PROJECTS
HEALTH SERVICES
HIGH-RISK
HIGH-RISK GROUPS
HIV
HIV INFECTION
HIV INFECTIONS
HIV PREVENTION
HIV TRANSMISSION
HOMOSEXUALITY
HOSPITALS
HUMAN IMMUNODEFICIENCY VIRUS
IMMUNE DEFICIENCY
IMMUNODEFICIENCY
INJECTABLE DRUGS
INJECTING DRUG USE
INTERNATIONAL ORGANIZATIONS
INTERVENTION
INTRAVENOUS DRUG USERS
LAWS
LEVELS OF POVERTY
LOW PREVALENCE
LUNG DISEASE
MALARIA
METHADONE
MIGRANT WORKERS
MIGRATION
MINISTRIES OF HEALTH
MODE OF TRANSMISSION
MORBIDITY
MORTALITY
NEEDLE EXCHANGE
NEEDLES
NEW CASES
OPPORTUNISTIC DISEASES
PALLIATIVE CARE
PARENTHOOD FEDERATION
PARTNERSHIP
PATIENTS
PEER EDUCATION
PREGNANT WOMEN
PREVENTION EFFORTS
PRISONS
PROSTITUTION
PUBLIC HEALTH
PUBLIC SECTOR
REFUGEES
REPRODUCTIVE HEALTH
RESISTANT TUBERCULOSIS
RISK BEHAVIOR
RISK FOR TRANSMISSION
RISK GROUPS
SAFE SEX
SAFER SEX
SCHOOL DROPOUTS
SCREENING
SEX WITH MEN
SEX WORKERS
SEXUAL TRANSMISSION
SEXUALLY TRANSMITTED INFECTIONS
SOCIAL SERVICES
STIS
SURVEILLANCE DATA
SYNDROMIC CASE MANAGEMENT
SYPHILIS
TB
TRANSMISSION
TREATMENT FOR AIDS
TUBERCULOSIS
UNAIDS
UNEMPLOYMENT
USE OF DRUGS
VOLUNTARY TESTING
VULNERABLE GROUPS
WORLD HEALTH ORGANIZATION
YOUNG PEOPLE
YOUTH
spellingShingle HIV AIDS INFECTIONS
TUBERCULOSIS EPIDEMICS
DRUG UTILIZATION
SEXUALLY TRANSMITTED INFECTIONS
UNEMPLOYMENT
IMPRISONMENT
POVERTY
HUMAN CAPITAL
ECONOMIC DEVELOPMENT
HEALTH SYSTEM MANAGEMENT
ECONOMIC ANALYSIS
STAKEHOLDER PARTICIPATION
EPIDEMIOLOGICAL INFORMATION
REGULATORY FRAMEWORK
PREVENTIVE HEALTH SERVICES
DIAGNOSTIC MEDICINE
TREATMENT
NONGOVERNMENTAL ORGANIZATIONS
STAKEHOLDER PARTICIPATION
ACQUIRED IMMUNE DEFICIENCY SYNDROME
ALS
CASE MANAGEMENT
CHILD TRANSMISSION
COMMERCIAL SEX
COMMERCIAL SEX WORKER
COMMERCIAL SEX WORKERS
CONDOMS
CRIME
DRUG ABUSE
DRUG RESISTANCE
DRUG TRAFFICKING
DRUG USERS
DRUGS
EFFECTIVE PREVENTION
EPIDEMIOLOGY
HARM REDUCTION
HEALTH CARE
HEALTH CARE SYSTEMS
HEALTH FOR ALL
HEALTH PROFESSIONALS
HEALTH PROJECTS
HEALTH SERVICES
HIGH-RISK
HIGH-RISK GROUPS
HIV
HIV INFECTION
HIV INFECTIONS
HIV PREVENTION
HIV TRANSMISSION
HOMOSEXUALITY
HOSPITALS
HUMAN IMMUNODEFICIENCY VIRUS
IMMUNE DEFICIENCY
IMMUNODEFICIENCY
INJECTABLE DRUGS
INJECTING DRUG USE
INTERNATIONAL ORGANIZATIONS
INTERVENTION
INTRAVENOUS DRUG USERS
LAWS
LEVELS OF POVERTY
LOW PREVALENCE
LUNG DISEASE
MALARIA
METHADONE
MIGRANT WORKERS
MIGRATION
MINISTRIES OF HEALTH
MODE OF TRANSMISSION
MORBIDITY
MORTALITY
NEEDLE EXCHANGE
NEEDLES
NEW CASES
OPPORTUNISTIC DISEASES
PALLIATIVE CARE
PARENTHOOD FEDERATION
PARTNERSHIP
PATIENTS
PEER EDUCATION
PREGNANT WOMEN
PREVENTION EFFORTS
PRISONS
PROSTITUTION
PUBLIC HEALTH
PUBLIC SECTOR
REFUGEES
REPRODUCTIVE HEALTH
RESISTANT TUBERCULOSIS
RISK BEHAVIOR
RISK FOR TRANSMISSION
RISK GROUPS
SAFE SEX
SAFER SEX
SCHOOL DROPOUTS
SCREENING
SEX WITH MEN
SEX WORKERS
SEXUAL TRANSMISSION
SEXUALLY TRANSMITTED INFECTIONS
SOCIAL SERVICES
STIS
SURVEILLANCE DATA
SYNDROMIC CASE MANAGEMENT
SYPHILIS
TB
TRANSMISSION
TREATMENT FOR AIDS
TUBERCULOSIS
UNAIDS
UNEMPLOYMENT
USE OF DRUGS
VOLUNTARY TESTING
VULNERABLE GROUPS
WORLD HEALTH ORGANIZATION
YOUNG PEOPLE
YOUTH
Godinho, Joana
Novotny, Thomas
Tadesse, Hiwote
Vinokur, Anatoly
HIV/AIDS and Tuberculosis in Central Asia
geographic_facet Europe and Central Asia
Central Asia
relation World Bank Working Paper;No. 20
description The countries of Central Asia are still at the earliest stages of an HIV/AIDS epidemic. However, there is cause for serious concern due to: the steep growth of new HIV cases in the region; the established related epidemics of injecting drug use, sexually transmitted infections (STIs) and tuberculosis (TB); youth representing more than 40 percent of the total regional population; and the low levels of knowledge about the epidemics. The underlying causes for the interlinked epidemics of drug abuse, HIV/AIDS, STIs and TB in Central Asia are many, including drug production in Afghanistan and its distribution throughout the Former Soviet Union (FSU); unemployment among youth; imprisonment for drug use; overcrowding in prisons; and striking levels of poverty. HIV/AIDS and tuberculosis may have a potentially devastating effect on human capital, economic development, and health systems reform. In Russia, economic analysis has described the significant future impact on health and health systems if the concentrated epidemic in that country goes unchecked (Ruhl et al. 2002). The opportunity for prevention in low prevalence environments provides an imperative for action, because when HIV prevalence among high-risk groups reaches 20 percent or more, prevention is no longer possible and expensive treatment for AIDS and related opportunistic infections will overwhelm under funded health care systems such as those in Central Asia. Low prevalence, or nascent epidemics of HIV create little incentive for focused attention. However, through careful consideration of the potential for these epidemics to grow, the World Bank can help client countries incorporate effective prevention strategies into health systems development projects or into specific public health projects to address these infections.
format Publications & Research :: Publication
author Godinho, Joana
Novotny, Thomas
Tadesse, Hiwote
Vinokur, Anatoly
author_facet Godinho, Joana
Novotny, Thomas
Tadesse, Hiwote
Vinokur, Anatoly
author_sort Godinho, Joana
title HIV/AIDS and Tuberculosis in Central Asia
title_short HIV/AIDS and Tuberculosis in Central Asia
title_full HIV/AIDS and Tuberculosis in Central Asia
title_fullStr HIV/AIDS and Tuberculosis in Central Asia
title_full_unstemmed HIV/AIDS and Tuberculosis in Central Asia
title_sort hiv/aids and tuberculosis in central asia
publisher Washington, DC: World Bank
publishDate 2013
url http://documents.worldbank.org/curated/en/2003/11/2875686/hivaids-tuberculosis-central-asia
http://hdl.handle.net/10986/15061
_version_ 1764425811337674752
spelling okr-10986-150612021-04-23T14:03:12Z HIV/AIDS and Tuberculosis in Central Asia Godinho, Joana Novotny, Thomas Tadesse, Hiwote Vinokur, Anatoly HIV AIDS INFECTIONS TUBERCULOSIS EPIDEMICS DRUG UTILIZATION SEXUALLY TRANSMITTED INFECTIONS UNEMPLOYMENT IMPRISONMENT POVERTY HUMAN CAPITAL ECONOMIC DEVELOPMENT HEALTH SYSTEM MANAGEMENT ECONOMIC ANALYSIS STAKEHOLDER PARTICIPATION EPIDEMIOLOGICAL INFORMATION REGULATORY FRAMEWORK PREVENTIVE HEALTH SERVICES DIAGNOSTIC MEDICINE TREATMENT NONGOVERNMENTAL ORGANIZATIONS STAKEHOLDER PARTICIPATION ACQUIRED IMMUNE DEFICIENCY SYNDROME ALS CASE MANAGEMENT CHILD TRANSMISSION COMMERCIAL SEX COMMERCIAL SEX WORKER COMMERCIAL SEX WORKERS CONDOMS CRIME DRUG ABUSE DRUG RESISTANCE DRUG TRAFFICKING DRUG USERS DRUGS EFFECTIVE PREVENTION EPIDEMIOLOGY HARM REDUCTION HEALTH CARE HEALTH CARE SYSTEMS HEALTH FOR ALL HEALTH PROFESSIONALS HEALTH PROJECTS HEALTH SERVICES HIGH-RISK HIGH-RISK GROUPS HIV HIV INFECTION HIV INFECTIONS HIV PREVENTION HIV TRANSMISSION HOMOSEXUALITY HOSPITALS HUMAN IMMUNODEFICIENCY VIRUS IMMUNE DEFICIENCY IMMUNODEFICIENCY INJECTABLE DRUGS INJECTING DRUG USE INTERNATIONAL ORGANIZATIONS INTERVENTION INTRAVENOUS DRUG USERS LAWS LEVELS OF POVERTY LOW PREVALENCE LUNG DISEASE MALARIA METHADONE MIGRANT WORKERS MIGRATION MINISTRIES OF HEALTH MODE OF TRANSMISSION MORBIDITY MORTALITY NEEDLE EXCHANGE NEEDLES NEW CASES OPPORTUNISTIC DISEASES PALLIATIVE CARE PARENTHOOD FEDERATION PARTNERSHIP PATIENTS PEER EDUCATION PREGNANT WOMEN PREVENTION EFFORTS PRISONS PROSTITUTION PUBLIC HEALTH PUBLIC SECTOR REFUGEES REPRODUCTIVE HEALTH RESISTANT TUBERCULOSIS RISK BEHAVIOR RISK FOR TRANSMISSION RISK GROUPS SAFE SEX SAFER SEX SCHOOL DROPOUTS SCREENING SEX WITH MEN SEX WORKERS SEXUAL TRANSMISSION SEXUALLY TRANSMITTED INFECTIONS SOCIAL SERVICES STIS SURVEILLANCE DATA SYNDROMIC CASE MANAGEMENT SYPHILIS TB TRANSMISSION TREATMENT FOR AIDS TUBERCULOSIS UNAIDS UNEMPLOYMENT USE OF DRUGS VOLUNTARY TESTING VULNERABLE GROUPS WORLD HEALTH ORGANIZATION YOUNG PEOPLE YOUTH The countries of Central Asia are still at the earliest stages of an HIV/AIDS epidemic. However, there is cause for serious concern due to: the steep growth of new HIV cases in the region; the established related epidemics of injecting drug use, sexually transmitted infections (STIs) and tuberculosis (TB); youth representing more than 40 percent of the total regional population; and the low levels of knowledge about the epidemics. The underlying causes for the interlinked epidemics of drug abuse, HIV/AIDS, STIs and TB in Central Asia are many, including drug production in Afghanistan and its distribution throughout the Former Soviet Union (FSU); unemployment among youth; imprisonment for drug use; overcrowding in prisons; and striking levels of poverty. HIV/AIDS and tuberculosis may have a potentially devastating effect on human capital, economic development, and health systems reform. In Russia, economic analysis has described the significant future impact on health and health systems if the concentrated epidemic in that country goes unchecked (Ruhl et al. 2002). The opportunity for prevention in low prevalence environments provides an imperative for action, because when HIV prevalence among high-risk groups reaches 20 percent or more, prevention is no longer possible and expensive treatment for AIDS and related opportunistic infections will overwhelm under funded health care systems such as those in Central Asia. Low prevalence, or nascent epidemics of HIV create little incentive for focused attention. However, through careful consideration of the potential for these epidemics to grow, the World Bank can help client countries incorporate effective prevention strategies into health systems development projects or into specific public health projects to address these infections. 2013-08-14T17:04:41Z 2013-08-14T17:04:41Z 2004 http://documents.worldbank.org/curated/en/2003/11/2875686/hivaids-tuberculosis-central-asia 0-8213-5687-9 http://hdl.handle.net/10986/15061 English en_US World Bank Working Paper;No. 20 CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank Washington, DC: World Bank Publications & Research :: Publication Publications & Research :: Publication Europe and Central Asia Central Asia